(Q44544709)

4 December 2017

Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race (English)

1 reference

secondary hyperparathyroidism

4 December 2017

1 reference

1 reference

Ali Owda

1

1 reference

4 December 2017

Huda Elhwairis

2

1 reference

4 December 2017

Sridhar Narra

3

1 reference

4 December 2017

Heather Towery

4

1 reference

4 December 2017

Sayed Osama

5

1 reference

4 December 2017

language of work or name

1 reference

1 July 2003

1 reference

4 December 2017

1 reference

4 December 2017

25

1 reference

4 December 2017

4

1 reference

4 December 2017

595-602

1 reference

Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited

4 December 2017

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Is there an optimal parathyroid hormone level in end-stage renal failure: the lower the better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Patients surviving 10 years of hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Early deposition of aluminum in bone in diabetic patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Diminished rates of bone formation in normal black adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Long-term intravenous calcitriol in secondary hyperparathyroidism: the role of technetium-99m-MIBI scintigraphy in predicting the response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Hyperparathyroidism in the hemodialysis population: a survey of 612 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Racial differences in bone mineral density and bone loss among end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Changes in parathyroid hormone in diabetic patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

Presence of sonographically detectable parathyroid glands can predict resistance to oral pulsed-dose calcitriol treatment of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJDI-120022551

21 January 2018

Identifiers

DOI

10.1081/JDI-120022551

1 reference

4 December 2017

1 reference